• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

What is the Validity of the SMFM/AFE Foundation Amniotic Fluid Embolism Criteria in a Population-based Cohort?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • SMFM and the Amniotic Fluid Embolism Foundation AFE Criteria
    • Sudden onset of cardiorespiratory arrest, or both hypotension (systolic blood pressure: < 90 mmHg) and respiratory insufficiency (dyspnea, cyanosis or peripheral capillary oxygen saturation < 90%)
    • DIC based on modified ISTH score >3
      • Platelets count: > 100,000/mL = 0 | < 100,000/mL = 1 | < 50,000/ mL = 2
      • Prolonged PT or INR: <25% increase = 0 | 25-50% increase = 1 | >50% increase = 2
      • Fibrinogen level: > 2 g/L = 0 | < 2 g/L = 1
    • Absence of fever (38 °C)
    • Onset during labor or within 30 minutes of delivery
  • Previous studies performed using data derived from registries demonstrated that all 4 criteria were not always present in cases highly suspicious for AFE
  • Ponzio-Klijanienkoa et al. (Journal of Gynecology Obstetrics and Human Reproduction, 2020) describe the first study to look at criteria in a population based-cohort  

METHODS:

  • Retrospective study (2006 to 2018)
    • Maternity unit in France
  • Participants
    • All patients strongly suspected of having AFE
  • Study design 
    • Suspicion of AFE
      • AFE clearly stated in chart
      • Positive biological tests (IGFBP-1 [protein found in amniotic fluid] dosage in blood and/or in bronchoalveolar lavage and presence of amniotic and fetal cells in the bronchoalveolar lavage) or
      • Autopsy in favor of an AFE diagnosis
  • Primary outcomes
    • Incidence rate of AFE
    • Presence of each of the 4 diagnostic criteria

RESULTS:

  • 54,140 women delivered during time frame of study
    • Strongly suspected of having AFE: 0.03%: 14 women
    • 25.9/100,000 deliveries (95% CI, 12.3 to 39.5/100,000)
  • Diagnostic criteria evaluation
    • Patients with all 4 criteria: 43% (6 of 14)
  • Criteria
    • Hemodynamic collapse: 100% (all 14 patients)
      • Respiratory symptoms: 43% (6 patients)
    • DIC (ISTH criteria): 71% (10 patients)
      • All patients had clinical coagulopathy (subjective impression of clinician including “excessive blood fluidity and absence of clotting) and a massive PPH (rapid blood loss of >1000 mL)
    • Absence of fever: 79% (11 patients) | 3 women with fever but no signs of sepsis
    • Onset during labor or within 30 minutes of delivery: 100% (all 14 patients)
    • All patients presented with ominous, premonitory symptoms prior to onset of AFE, including neurological disorders or irreversible fetal bradycardia
    • 1 maternal death (autopsy confirmed AFE)
  • Confirmation of AFE based on study protocol
    • Bronchoalveolar lavage containing amniotic and fetal cells: 4 patients
    • Increased plasmatic concentration of IGFBP-1: 10 patients

CONCLUSION:

  • <50% of patients with a strong suspicion of AFE fulfilled all 4 AFE criteria
  • Although all patients had a clinical diagnosis of coagulopathy, they did not always meet the modified ISTH score | Other scoring systems may be better suited for use in AFE
  • Low grade fever is not unusual during labor (e.g., use of epidural)
  • The authors suggest that premonitory signs are recognized by other professional organizations (e.g., United Kingdom Obstetric Surveillance System) and could be included in the AFE definition criteria such as

Neurological signs (seizure, confusion, agitation, fainting or anxiety and imminent death feeling), abnormal fetal heart rate, respiratory signs (dyspnea, cough, shortness of breath), and atypical signs (nausea and/or vomiting, arterial blood hypertension, skin rash, thoracic or abdominal pain)

Learn More – Primary Sources:

Evaluation of The 4 Diagnosis Criteria Proposed By The SMFM And The AFE Foundation For Amniotic Fluid Embolism In A Monocentric Population

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Peripartum Cardiomyopathy: Definitions, Diagnosis and Management
Pregnancy-Related Deaths in the U.S.: How Many are Preventable?
Results of the SALVO Trial: Cell Salvage During Cesarean Section

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site